Delivery Order 36F79720D0214-36C24521F0489
Award Date 8/3/21
Potential Completion Date 8/5/21
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27518, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Chiesi USA Inc. was awarded a $13,550.54 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to provide 1,000 mg doses of DEFERIPRONE to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order has a completion date of February 22, 2022 and was awarded on February 17, 2022 out of Cary, North Carolina to support the VA's healthcare programs. No set-aside designation was applied to...
- This is a $6,895.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of 4,564,401,183 tablets of Deferiprone 500 mg, an iron chelator drug. The delivery order was issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to order a...
- The Defense Logistics Agency awarded a $10,368 delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg granule packets (30 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award was competitively awarded without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $32,834.44 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units) with a completion date of December 4, 2025. The award, issued on December 3, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this delivery order from its...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $10,105.40 delivery order to Insmed Inc. on March 21, 2025, for an emergency pharmacy order to be performed in Carrollton, Texas. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents an urgent pharmaceutical supply need within the VA's healthcare network. The award was issued under Insmed's existing Multiple Award Federal Supply Schedule contract (FSS) for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $28,655.27 and an ultimate completion date of October 28, 2025. The contract involves no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 360 MG TABLET 30S, a medical product, with a ceiling value of $54,663.84 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $15,789.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,092,751 units of the medication Deferasirox 500 mg tablets for suspension, with a performance period ending on May 1, 2025. The contract is not set-aside and was awarded on a firm-fixed-price basis. Amerisourcebergen Drug Corp, the prime...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,131.67 delivery order to Catalyst Pharmaceuticals, Inc. for FIRDAPSE 10MG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with a firm fixed price and performance location in Miami, Florida. No set-aside designation was used for this order to supply the drug FIRDAPSE to the agency, which provides healthcare services to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract type. The award, valued at approximately $24.9K, was competitively awarded without set-aside designation and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0214Federal Supply Schedule
- 36F79720D0214-36C24521F0489Delivery Order
Chiesi USA Inc. was awarded an $18,987.63 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) to provide 1,000 mg DEFERIPRONE to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. Place of performance will be in Cary, North Carolina. No set-aside designation was applied to this contract, which is to be completed by August 5, 2021. Chiesi USA Inc. will serve as the prime contractor to deliver the requested pharmaceutical product in support of the VA's healthcare programs for veterans in the designated region.
Generated 1/2/24, 10:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 8/3/21 |